Skip to main content
Top
Published in: Radiation Oncology 1/2019

Open Access 01-12-2019 | Nausea | Research

Dosimetric factors associated with long-term patient-reported outcomes after definitive radiotherapy of patients with head and neck cancer

Authors: Toyokazu Hayakawa, Shogo Kawakami, Itaru Soda, Takuro Kainuma, Marika Nozawa, Akane Sekiguchi, Shunsuke Miyamoto, Taku Yamashita, Hiromichi Ishiyama

Published in: Radiation Oncology | Issue 1/2019

Login to get access

Abstract

Background

The aim of this study was to explore the relationships between dosimetric parameters of organs at risk and patient-reported outcomes (PRO) after radiotherapy of patients with head and neck cancer.

Methods

PRO data of 53 patients with head and neck cancer treated with radiotherapy were prospectively collected. These data concerned health-related quality of life (HRQOL) and were collected using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) and head and neck cancer module (QLQ-H&N35). Patients were divided into “severe-deterioration” and “mild-deterioration” groups on the basis of degree of deterioration HRQOL > 6 months after completing treatment. The relationships between HRQOL deteriorations and patient-related or dosimetry-related factors were evaluated. P < 0.0013 according to Bonferroni correction was considered to denote statistical significance.

Results

Regarding “trouble with social eating (HNSO)” and “coughing (HNCO),” there were significant differences between the severe-deterioration and mild-deterioration groups in mean dosages to the superior pharyngeal constrictor muscle (SPC) (HNSO: 62.5 Gy vs 54.2 Gy; p = 0.00029, and HNCO: 61.5 Gy vs 54.1 Gy; p = 0.0012) and parotid gland (HNSO: 24.1 Gy vs 20.5 Gy; p = 0.000056, and HNCO: 24.2 Gy vs 20.3 Gy; p = 0.00043). Regarding “nausea and vomiting,” there was a significant difference between the two groups in the mean dosage to the middle pharyngeal constrictor muscle (MPC: 61.9 Gy vs. 58.4Gy; P = 0.00059).

Conclusions

We found that dosages to the SPC and parotid gland were associated with severe deterioration in HRQOL attributable to difficulty in HNSO and HNCO, whereas dosage to the MPC was associated with severe deterioration attributable to nausea and vomiting.
Appendix
Available only for authorised users
Literature
1.
go back to reference Babic T, Browning KN. The role of vagal neurocircuits in the regulation of nausea and vomiting. Eur J Pharmacol. 2014;722:38–47.CrossRef Babic T, Browning KN. The role of vagal neurocircuits in the regulation of nausea and vomiting. Eur J Pharmacol. 2014;722:38–47.CrossRef
2.
go back to reference Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med. 2010;362:865–9.CrossRef Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med. 2010;362:865–9.CrossRef
3.
go back to reference Caudell JJ, et al. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2010;76:403–9.CrossRef Caudell JJ, et al. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2010;76:403–9.CrossRef
4.
go back to reference Chera BS, et al. Dosimetric predictors of patient-reported xerostomia and dysphagia with deintensified chemoradiation therapy for hpv-associated oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2017;98:1022–7.CrossRef Chera BS, et al. Dosimetric predictors of patient-reported xerostomia and dysphagia with deintensified chemoradiation therapy for hpv-associated oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2017;98:1022–7.CrossRef
5.
go back to reference Dirix P, et al. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2009;75:385–92.CrossRef Dirix P, et al. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2009;75:385–92.CrossRef
6.
go back to reference Fayers PM, et al. The eortc qlq-c30 scoring manual. 3rd ed. Brussels: European Organisation for Research and Treatment of Cancer; 2001. Fayers PM, et al. The eortc qlq-c30 scoring manual. 3rd ed. Brussels: European Organisation for Research and Treatment of Cancer; 2001.
7.
go back to reference Gregoire V, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. Dahanca, eortc, hknpcsg, ncic ctg, ncri, rtog, trog consensus guidelines. Radiother Oncol. 2014;110:172–81.CrossRef Gregoire V, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. Dahanca, eortc, hknpcsg, ncic ctg, ncri, rtog, trog consensus guidelines. Radiother Oncol. 2014;110:172–81.CrossRef
8.
go back to reference Mortensen HR, et al. Late dysphagia after imrt for head and neck cancer and correlation with dose-volume parameters. Radiother Oncol. 2013;107:288–94.CrossRef Mortensen HR, et al. Late dysphagia after imrt for head and neck cancer and correlation with dose-volume parameters. Radiother Oncol. 2013;107:288–94.CrossRef
9.
go back to reference Nishimura Y, et al. A two-step intensity-modulated radiation therapy method for nasopharyngeal cancer: the kinki university experience. Jpn J Clin Oncol. 2010;40:130–8.CrossRef Nishimura Y, et al. A two-step intensity-modulated radiation therapy method for nasopharyngeal cancer: the kinki university experience. Jpn J Clin Oncol. 2010;40:130–8.CrossRef
10.
go back to reference Osoba D, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139–44.CrossRef Osoba D, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139–44.CrossRef
11.
go back to reference Popovtzer A, et al. Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: Mri-based study. Radiother Oncol. 2009;93:510–5.CrossRef Popovtzer A, et al. Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: Mri-based study. Radiother Oncol. 2009;93:510–5.CrossRef
12.
go back to reference Rhodus NL, et al. Quantitative assessment of dysphagia in patients with primary and secondary Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:305–10.CrossRef Rhodus NL, et al. Quantitative assessment of dysphagia in patients with primary and secondary Sjogren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:305–10.CrossRef
13.
go back to reference Sanguineti G, et al. Predictors of peg dependence after imrt+/−chemotherapy for oropharyngeal cancer. Radiother Oncol. 2013;107:300–4.CrossRef Sanguineti G, et al. Predictors of peg dependence after imrt+/−chemotherapy for oropharyngeal cancer. Radiother Oncol. 2013;107:300–4.CrossRef
14.
go back to reference Sun Y, et al. Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy. Radiother Oncol. 2014;110:390–7.CrossRef Sun Y, et al. Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy. Radiother Oncol. 2014;110:390–7.CrossRef
15.
go back to reference Vainshtein JM, et al. Impact of xerostomia on dysphagia after chemotherapy-intensity-modulated radiotherapy for oropharyngeal cancer: prospective longitudinal study. Head Neck. 2016;38(Suppl 1):E1605–12.CrossRef Vainshtein JM, et al. Impact of xerostomia on dysphagia after chemotherapy-intensity-modulated radiotherapy for oropharyngeal cancer: prospective longitudinal study. Head Neck. 2016;38(Suppl 1):E1605–12.CrossRef
16.
go back to reference Wopken K, Bijl HP, Langendijk JA. Prognostic factors for tube feeding dependence after curative (chemo-) radiation in head and neck cancer: a systematic review of literature. Radiother Oncol. 2018;126:56–67.CrossRef Wopken K, Bijl HP, Langendijk JA. Prognostic factors for tube feeding dependence after curative (chemo-) radiation in head and neck cancer: a systematic review of literature. Radiother Oncol. 2018;126:56–67.CrossRef
17.
go back to reference Wopken K, et al. Development of a multivariable normal tissue complication probability (ntcp) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer. Radiother Oncol. 2014;113:95–101.CrossRef Wopken K, et al. Development of a multivariable normal tissue complication probability (ntcp) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer. Radiother Oncol. 2014;113:95–101.CrossRef
Metadata
Title
Dosimetric factors associated with long-term patient-reported outcomes after definitive radiotherapy of patients with head and neck cancer
Authors
Toyokazu Hayakawa
Shogo Kawakami
Itaru Soda
Takuro Kainuma
Marika Nozawa
Akane Sekiguchi
Shunsuke Miyamoto
Taku Yamashita
Hiromichi Ishiyama
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2019
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-019-1429-3

Other articles of this Issue 1/2019

Radiation Oncology 1/2019 Go to the issue